Schiviz, Alexandra Nathalie,Höllriegl, Werner,Plaimauer, Barbara,Rottensteiner, Hanspeter,Muchitsch, Eva Maria
申请号：
AU2016231547
公开号：
AU2016231547B2
申请日:
2016.09.22
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2016231547B220180315.pdf#####ABSTRACT This invention relates to methods of subcutaneous administration of ADAMTS 13 formulations to a treat a disease or condition associated with ADAMTS 13 and VWF dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS 13 formulations administered subcutaneously is provided herein. 38
